<?xml version="1.0" encoding="UTF-8"?>
<p>The HEV 239 vaccine (Hecolin; Xiamen Innovax Biotech, Xiamen, China) is a 26 kDa recombinant polypeptide corresponding to amino acid residues 368–606 of the capsid protein of a genotype 1 HEV strain 
 <xref rid="pone.0087600-Li2" ref-type="bibr">[16]</xref>. The vaccine is expressed in 
 <italic>Escherichia coli</italic> (
 <italic>E. coli</italic>) and vaccine doses contain 30 µg of the purified antigen in 0.5 mL buffered saline adsorbed to 0.8 mg aluminium hydroxide.
</p>
